years

L’OCCITANE Group celebrates 50 years of L’Occitane en Provence

GENEVA, Jan. 12, 2026 /PRNewswire/ -- L'OCCITANE Group is proud to announce the 50th anniversary of L'Occitane en Provence, its…

3 months ago

Pole Star Global launches Maritime Transparency Index — turning 25 years of maritime intelligence into instant vessel and voyage risk verdicts

LONDON, Jan. 6, 2026 /PRNewswire/ -- Pole Star Global, a world leader in maritime intelligence and regulatory compliance solutions, today announced…

3 months ago

ASUS Republic of Gamers Presents Next-Gen Gaming Innovations, Commemorates 20 Years of Gaming Excellence at CES 2026

KEY POINTS Two decades of gaming leadership: At its Dare to Innovate virtual event, ROG celebrates 20 years of fearless…

3 months ago

GAC’s Global Ecosystem Takes Shape as Overseas Sales Nearly Triple in Two Years

GUANGZHOU, China, Jan. 1, 2026 /PRNewswire/ -- GAC released its 2025 overseas performance report, announcing exports of over 130,000 vehicles,…

3 months ago

NANOscientific Symposium Series 2025 Concludes Successfully, Marked by a Landmark Celebration of 40 Years of AFM at Stanford

STANFORD, Calif., Dec. 24, 2025 /PRNewswire/ -- The NANOscientific Symposium Series (NSS) 2025 has successfully concluded its global program, bringing together…

4 months ago

FP Markets Celebrates 20 Years of Transforming Trading and Looks Ahead to a New Era of Growth

SYDNEY, Dec. 24, 2025 /PRNewswire/ -- Global multi-asset broker FP Markets proudly marked its twentieth anniversary this year, celebrating two decades…

4 months ago

REPLUS marks seven years of growth as an integrated clean energy and electric mobility company

PUNE, India, Dec. 24, 2025 /PRNewswire/ -- Founded with the objective of solving real-world energy challenges, REPLUS today operates as a fully…

4 months ago

Press Release: Sanofi and Regenerons Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma

Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma Approval based on…

4 months ago

Dupixent (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma

Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved…

4 months ago

PM SHRI Kendriya Vidyalaya No. 1, Patiala Cantt Celebrates 50 Years of Excellence with Golden Jubilee Programme

PATIALA, India, Dec. 22, 2025 /PRNewswire/ -- MSITEK -- PM SHRI Kendriya Vidyalaya No. 1, Patiala Cantt marked a historic…

4 months ago